Birgit Nagl
Vienna, 1090, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
NSG mice humanized with allergen-specific T-cell lines as in vivo model of respiratory allergy.
Journal: Allergy
Published: December 12, 2019
Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human/mouse chimeric model.
Journal: Allergy
Published: November 15, 2017
Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy.
Journal: The Journal of allergy and clinical immunology
Published: April 20, 2017
Critical role of mammalian target of rapamycin for IL-10 dendritic cell induction by a flagellin A conjugate in preventing allergic sensitization.
Journal: The Journal of allergy and clinical immunology
Published: November 07, 2016
Characterization of the T-cell response to Dau c 1, the Bet v 1-homolog in carrot.
Journal: Allergy
Published: May 22, 2016
Tackling Bet v 1 and associated food allergies with a single hybrid protein.
Journal: The Journal of allergy and clinical immunology
Published: March 14, 2016
Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
Journal: The Journal of allergy and clinical immunology
Published: February 16, 2012
Last Updated: 09/26/2026